IL1B and poliomyelitis: 17 patients with auto-inflammatory disorder sJIA, 5 CAPS, 4 MKD, 1 FMF14 on anti-IL-1, 3 on anti-IL-67 received MMR boost1 received first dose of MMR/VZV while on canakinumab, which was stopped at time of vaccination1 received first dose of VZV while on tocilizumab4 received first Yellow fever1 received oral polio while on tocilizumab